Skip to main content

Advertisement

SpringerLink
Log in

Vitamin D and the D-Hormones, Alfacalcidol and Calcitriol, as Therapeutic Agents for Osteoporotic Populations

  • Editorial
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lindsay R (1988) Role of estrogen in the prevention of osteoporosis. In: Watts NB (ed) Endocrinology and metabolism clinics in North America. WB Saunders, Philadelphia, pp 399–409

    Google Scholar 

  2. Watts NB (1988) Treatment of osteoporosis with bisphosphonates. In: Watts NB (ed) Endocrinology and metabolism clinics in North America. WB Saunders, Philadelphia, pp 419–439

    Google Scholar 

  3. Avioli LV (1988) Role of calcitonin in the prevention of osteoporosis. In: Watts NG (ed) Endocrinology and metabolism clinics in North America. WB Saunders, Philadelphia, pp 411–418

    Google Scholar 

  4. Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, Draper M, Christiansen C (1997) Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 337:1641–1647

    Article  CAS  PubMed  Google Scholar 

  5. Heaney RP, Draper MW (1997) Raloxifene and estrogen: comparative bone-remodeling kinetics. J Clin Endocrinol Metab 82:3425–3429

    CAS  PubMed  Google Scholar 

  6. Walters MR (1992) Newly identified actions of the vitamin D endocrine system. Endocr Rev 13:719–764

    CAS  PubMed  Google Scholar 

  7. Kinyamu HK, Gallagher JC, Rafferty KA, Balhom KE (1998) Dietary calcium and vitamin D intake in elderly women: effect on serum parathyroid hormone and vitamin D metabolites. Am J Clin Nutr 67:342–348

    CAS  PubMed  Google Scholar 

  8. Liu BA, Gordon M, Labranche JM, Murray TM, Vieth R, Shear NH ( 1997) Seasonal prevalence of vitamin D deficiency in institutionalized older adults. JAGS 45:598–603

    CAS  Google Scholar 

  9. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS (1998) Hypovitaminosis D in medical inpatients. N Engl J Med 338:777–783

    Article  CAS  PubMed  Google Scholar 

  10. Kinyamu HK, Gallagher JC, Balhom KE, Petranick KM, Rafferty KA (1997) Serum vitamin D metabolites and calcium absorption in normal young and elderly free-living women and in women living in nursing homes. Am J Clin Nutr 65: 790–797

    CAS  PubMed  Google Scholar 

  11. Jacques PF, Felson DT, Tucker KL, Nahnken B, Wilson PWF, Rosenberg IH, Rush D (1997) Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample. Am J Clin Nutr 66:929–936

    CAS  PubMed  Google Scholar 

  12. Gloth FM III, Gundberg CM, Hollis BW, Haddad JG Jr, Tobin JD (1995) Vitamin D deficiency in homebound elderly persons. JAMA 274:1683–1686

    Article  PubMed  Google Scholar 

  13. Utiger RD (1998) The need for more vitamin D. N Engl J Med 338:828–829

    Article  CAS  PubMed  Google Scholar 

  14. Villareal DT, Civitelli R, Chines A, Avioli LV (1991) Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass. J Clin Endocrinol Metab 72:628–634

    Article  CAS  PubMed  Google Scholar 

  15. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637–1642

    Article  CAS  PubMed  Google Scholar 

  16. Kato S, Sekine K, Matsumoto T, Yoshizawa T (1998) Molecular genetics of vitamin D receptor acting in bone. J Bone Miner Metab 16:65–71

    Article  CAS  Google Scholar 

  17. Manolagas SC, Haussler MR, Deftos LJ ( 1980) 1,25-Dihydroxyvitamin D3 receptor-like macromolecule in rat osteogenic sarcoma cell lines. J Biol Chem 255:4414–4417

    CAS  PubMed  Google Scholar 

  18. Narbaitz R, Stumpf WE, Sar M, Huang S, DeLuca HF (1983) Autoradiographic localization of target cells for 1,25-dihydroxyvitamin D3 in bones from fetal rats. Calcif Tissue Int 35:177–182

    Article  CAS  PubMed  Google Scholar 

  19. Yoon K, Rutledge SC, Buenaga RF, Rodan GA (1988) Characterization of the rat osteocalcin gene: stimulation of promoter activity by 1,25-dihydroxyvitamin D3. Biochemistry 27:8521–8526

    Article  CAS  PubMed  Google Scholar 

  20. Demay MB, Roth DA, Kronenberg HM (1989) Regions of the rat osteocalcin gene which mediate the effect of 1,25-dihydroxyvitamin D3 on gene transcription. J Biol Chem 264: 2279–2282

    CAS  PubMed  Google Scholar 

  21. Fraser JD, Otawara Y, Price PA (1988) 1,25-Dihydroxyvitamin D3 stimulates the synthesis of matrix-carboxyglutamic acid protein by osteosarcoma cells. J Biol Chem 263: 911–916

    CAS  PubMed  Google Scholar 

  22. Prince CW, Butler WT (1987) 1,25-Dihyrdroxyvitamin D regulates the biosynthesis of osteopontin, a bone-derived, cell attachment protein. Collagen Rel Res 7:305–313

    Article  CAS  Google Scholar 

  23. Noda M, Yoon K, Prince CW, Butler WT, Rodan GA (1988) Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type β transforming growth factor. J Biol Chem 263:13916–13921

    CAS  PubMed  Google Scholar 

  24. Franceschi RT, James WM, Zerlauth G (1985) 1α,25-Dihydroxyvitamin D specific regulation of Dihydroxyvitamin D specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line. J Cell Physiol 123:401–409

    Article  CAS  PubMed  Google Scholar 

  25. Majeska RJ, Rodan GA (1982) The effect of 1,25(OH)D2D3 on alkaline phosphatase in osteoblastic osteosarcoma cells. J Biol Chem 257:3362–3365

    CAS  PubMed  Google Scholar 

  26. Mulkins MA, Manolagas SC, Deftos LJ, Sussman HH (1983) 1,25-Dihydroxyvitamin D3 increases bone alkaline phosphatase enzyme levels in human osteogenic sarcoma cells. J Biol Chem 258:6219–6225

    CAS  PubMed  Google Scholar 

  27. Beresford JN, Gallagher JA, Russell RGG (1986) 1,25-Dihydroxyvitamin D3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation. Endocrinology 119:1776–1785

    Article  CAS  PubMed  Google Scholar 

  28. Wong GL, Luben RA, Cohn DV (1977) 1,25-Dihydroxycholecalciferol and parahormone: effects on isolated osteoclast-like and osteoblast-like cells. Science 197:663–665

    Article  CAS  PubMed  Google Scholar 

  29. Raisz LG, Maina GM, Gworek SC, Dietrich JW, Canalis E (1977) Hormonal control of bone collagen synthesis in vitro. Inhibitory effect of 1-hydroxylated vitamin D metabolites. Endocrinology 102:731–735

    Article  Google Scholar 

  30. Kream BE, Rowe D, Smith MD, Maher V, Majeska RJ (1986) Hormonal regulation of collagen synthesis in a clonal rat osteosarcoma cell line. Endocrinology 119:1922–1928

    Article  CAS  PubMed  Google Scholar 

  31. Franceschi RT, Romano PR, Park K (1988) Regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D3 in human osteosarcoma cells. J Biol Chem 263:18938–18945

    CAS  PubMed  Google Scholar 

  32. Kurihara N, Ishizuka S, Kiyoki M, Haketa Y, Ikeda K, et al. (1986) Effects of 1,25-dihydroxyvitamin D3 on osteoblastic MC3T3-E1 cells. Endocrinology 118:940–947

    Article  CAS  PubMed  Google Scholar 

  33. Kelly KA, Gimble JM (1998) 1,25-Dihydroxyvitamin D3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures. Endocrinology 139:2622–2628

    CAS  PubMed  Google Scholar 

  34. Haussler MR, Whitfield GK, Haussler CA, Hsieh J-C, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13:325–349

    Article  CAS  PubMed  Google Scholar 

  35. Jingushi S, Iwaki A, Higuchi O, Axuma Y, Ohta T, Shida J-I, Izumi T, Ikenoue T, Sugioka Y, Iwamoto Y (1998) Serum 1α,25-dihydroxyvitamin D3 accumulates into the fracture callus during rat femoral fracture healing. Endocrinology 139: 1467–1473

    CAS  PubMed  Google Scholar 

  36. Schutze N, Lechner A, Groll C, Siggelkow H, Hufner M, Kohrle J, Jakob F (1998) The human analog of murine cystein-rich protein 16 is a 1α,25-dihydroxyvitamin D3-responsive, immediate early gene in human fetal osteoblasts: regulation by cytokines, growth factors, and serum. Endocrinology 139:1761–1770

    CAS  PubMed  Google Scholar 

  37. Erben RG, Schutt AM, Miao D, Kollenkirchen U, Haberey M (1997) Short-term treatment of rats with high dose 1,25-dihydroxyvitamin D3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow. Endocrinology 138:4629–4635

    CAS  PubMed  Google Scholar 

  38. Kurihara N, Ishizuka S, Tatsumi J, Arai F, Ikeda K, Roodman GD (1998) 23(S)25(R)-1,25-dihydroxyvitamin D3-lactone, a naturally occurring metabolite of 1,25-dihydroxyvitamin D3, inhibits osteoclast-like cell formation in human bone marrow cultures. J Bone Miner Metab 16:5–10

    Article  CAS  Google Scholar 

  39. Aloia JF, Vaswani A, Yeh JF (1988) Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med 84:401–408

    Article  CAS  PubMed  Google Scholar 

  40. Gallagher JC, Riggs BL (1990) Action of 1,25-dihydroxyvitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate. Metabolism 39(4)(suppl 1): 30–34

    Article  CAS  PubMed  Google Scholar 

  41. Gallagher JC, Riggs BL, Recker RR, Goldgar D (1989) The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency. Proc Soc Exp Biol Med 191:287–292

    Article  CAS  PubMed  Google Scholar 

  42. Caniggia A, Nuti R, Lore F, Martini G, Turchetti V, Righi G (1990) Long-term treatment with calcitriol in postmenopausal osteoporosis. Metabolism 39(4)(suppl 1):43–49

    Article  CAS  PubMed  Google Scholar 

  43. Dambacher MA, Neff M, Kissling R, Qin L (1998) Highly precise peripheral quantitative computed tomography for the evaluation of bone density, loss of bone density and structures. Drugs Aging 12:15–24

    Article  PubMed  Google Scholar 

  44. Barton DH, Hesse HR, Pechet MM, Rizzardo E (1973) A convenient synthesis of 1αvitamin D3. J Am Chem Soc 95: 2748–2749

    Article  CAS  PubMed  Google Scholar 

  45. Civitelli R (1995) Role of vitamin D metabolites in treatment of osteoporosis. Calcif Tissue Int 57:409–414

    Article  CAS  PubMed  Google Scholar 

  46. Orimo H, Shiraki M, Hayashi T, Nakamura T (1987) Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1α(OH)D3. Bone Miner 3:47–52

    CAS  PubMed  Google Scholar 

  47. Shiraki M, Itoh H, Orimo H (1993) The ultra long-term treatment of senile osteoporosis with 1 alpha-hydroxyvitamin D3. Bone Miner 20:223–234

    Article  CAS  PubMed  Google Scholar 

  48. Caniggia A, Nuti R, Lore F, Martini G, Fredian B, Giovani S (1993) Total body absorptiometry in postmenopausal osteoporosis patients treated with one alpha-hydroxylated vitamin D metabolites. Osteoporosis Int (suppl 1):S181–S185

    Google Scholar 

  49. Orimo H, Shiraki M, Hayashi Y, Hoshino T, Onaya T, Miyazaki S, Kurosawa H, Nakamura T, Ogawa N (1994) Effects of 1α-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 54:370–376

    Article  CAS  PubMed  Google Scholar 

  50. Pouilles JM, Tremollieres F, Ribot C (1992) Prevention of postmenopausal bone loss with 1 alpha-hydroxyvitamin D3: a three-year prospective study. Clin Rheumatol 11:1492–1497

    Article  Google Scholar 

  51. Shiraki M (1993) Treatment of osteoporosis with vitamin D3. Osteoporosis Int (suppl 1):S176–S180

    Google Scholar 

  52. DeLuca HF (1997) 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of osteoporosis. Osteoporosis Int 7:S24–S29

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Bone and Mineral Diseases, Washington University School of Medicine, 216 South Kingshighway Blvd., St. Louis, Missouri, 63110, USA

    L. V. Avioli

Authors
  1. L. V. Avioli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Avioli, L.V. Vitamin D and the D-Hormones, Alfacalcidol and Calcitriol, as Therapeutic Agents for Osteoporotic Populations. Calcif Tissue Int 65, 292–294 (1999). https://doi.org/10.1007/s002239900701

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002239900701

Search

Navigation